Category: Insights

What We Know From 4-Plus Years of Drug Patent Challenges Heard by the PTAB

While the Patent Trial and Appeal Board invalidates Orange Book-listed patents less than 20 percent of the time, it accepts 66 percent of petitions from generic drugmakers and takes no…
The post What We Know From 4-Plus Years of Drug Patent Chall…


Biotechblog